Loading...

Biotin anti-mouse CD3ε Antibody Biotin anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
1_145-2C11_Biotin_021606
C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 1_145-2C11_Biotin_021606
    C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 2_145-2C11_Biotin_CD3e_Antibody_2_010620
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for 10 minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/ml of biotin anti-mouse CD3ε (clone 145-2C11), Alexa Fluor® 594 anti-mouse B220 (clone RA3-6B2) (blue), and Alexa Fluor® 488 anti-mouse CD29 (clone HMβ1-1) (green) overnight at 4°C, followed by 2.5 µg/ml of Spark YG™ 570 Streptavidin (red) for 2 hours at room temperature. The image was captured by 10X objective.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100304 500 µg SEK1017
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100303 50 µg SEK353
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. For immunohistochemistry, a concentration range of 5.0 - 10 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Song R, et al. 2022. Immunology. 165:274. PubMed
  3. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  4. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  5. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  6. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  7. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  8. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  9. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  10. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  11. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  12. Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed
  13. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  14. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  15. Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed
  16. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  17. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  18. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  19. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  20. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  21. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  22. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  23. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  24. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  25. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  26. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  27. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  28. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  29. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  30. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  31. Lu SX, et al. 2021. Cell. . PubMed
  32. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  33. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  34. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  35. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  36. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  37. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  38. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  39. Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed
  40. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  41. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  42. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  43. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  44. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  45. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  46. Köchl R, et al. 2020. Elife. 9:00. PubMed
  47. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  48. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  49. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  50. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  51. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  52. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  53. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  54. Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed
  55. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  56. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  57. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  58. Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed
  59. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  60. Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed
  61. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  62. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  63. Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed
  64. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  65. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  66. Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed
  67. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  68. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  69. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  70. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  71. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  72. Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed
  73. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  74. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  75. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  76. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  77. Koide S, et al. 2022. iScience. 25:103603. PubMed
  78. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  79. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  80. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  81. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  82. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  83. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  84. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  85. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  86. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  87. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  88. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  89. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  90. Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed
  91. Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed
  92. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  93. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  94. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  95. Deets KA, et al. 2021. Elife. 10:. PubMed
  96. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  97. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  98. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  99. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  100. Muro R, et al. 2015. PLoS One. 10:119898. PubMed
  101. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  102. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  103. Song R, et al. 2022. Immunology. 165:274. PubMed
  104. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  105. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  106. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  107. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  108. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  109. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  110. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  111. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  112. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  113. Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed
  114. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  115. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  116. Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed
  117. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  118. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  119. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  120. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  121. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  122. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  123. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  124. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  125. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  126. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  127. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  128. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  129. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  130. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  131. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  132. Lu SX, et al. 2021. Cell. . PubMed
  133. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  134. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  135. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  136. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  137. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  138. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  139. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  140. Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed
  141. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  142. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  143. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  144. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  145. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  146. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  147. Köchl R, et al. 2020. Elife. 9:00. PubMed
  148. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  149. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  150. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  151. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  152. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  153. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  154. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  155. Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed
  156. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  157. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  158. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  159. Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed
  160. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  161. Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed
  162. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  163. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  164. Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed
  165. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  166. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  167. Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed
  168. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  169. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  170. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  171. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  172. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  173. Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed
  174. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  175. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  176. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  177. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  178. Koide S, et al. 2022. iScience. 25:103603. PubMed
  179. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  180. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  181. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  182. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  183. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  184. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  185. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  186. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  187. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  188. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  189. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  190. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  191. Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed
  192. Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed
  193. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  194. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  195. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  196. Deets KA, et al. 2021. Elife. 10:. PubMed
  197. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  198. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  199. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  200. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  201. Muro R, et al. 2015. PLoS One. 10:119898. PubMed
  202. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_312669 (BioLegend Cat. No. 100304)
AB_312668 (BioLegend Cat. No. 100303)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
1_145-2C11_Biotin_021606
C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 1_145-2C11_Biotin_021606
    C57BL/6 mouse splenocytes were stained with biotinylated CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by Sav-PE.
  • 2_145-2C11_Biotin_CD3e_Antibody_2_010620
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for 10 minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/ml of biotin anti-mouse CD3ε (clone 145-2C11), Alexa Fluor® 594 anti-mouse B220 (clone RA3-6B2) (blue), and Alexa Fluor® 488 anti-mouse CD29 (clone HMβ1-1) (green) overnight at 4°C, followed by 2.5 µg/ml of Spark YG™ 570 Streptavidin (red) for 2 hours at room temperature. The image was captured by 10X objective.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100304 500 µg SEK1017
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100303 50 µg SEK353
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. For immunohistochemistry, a concentration range of 5.0 - 10 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  2. Song R, et al. 2022. Immunology. 165:274. PubMed
  3. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  4. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  5. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  6. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  7. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  8. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  9. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  10. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  11. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  12. Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed
  13. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  14. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  15. Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed
  16. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  17. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  18. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  19. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  20. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  21. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  22. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  23. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  24. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  25. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  26. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  27. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  28. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  29. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  30. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  31. Lu SX, et al. 2021. Cell. . PubMed
  32. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  33. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  34. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  35. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  36. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  37. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  38. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  39. Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed
  40. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  41. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  42. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  43. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  44. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  45. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  46. Köchl R, et al. 2020. Elife. 9:00. PubMed
  47. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  48. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  49. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  50. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  51. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  52. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  53. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  54. Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed
  55. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  56. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  57. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  58. Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed
  59. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  60. Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed
  61. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  62. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  63. Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed
  64. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  65. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  66. Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed
  67. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  68. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  69. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  70. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  71. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  72. Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed
  73. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  74. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  75. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  76. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  77. Koide S, et al. 2022. iScience. 25:103603. PubMed
  78. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  79. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  80. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  81. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  82. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  83. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  84. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  85. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  86. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  87. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  88. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  89. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  90. Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed
  91. Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed
  92. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  93. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  94. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  95. Deets KA, et al. 2021. Elife. 10:. PubMed
  96. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  97. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  98. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  99. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  100. Muro R, et al. 2015. PLoS One. 10:119898. PubMed
  101. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  102. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  103. Song R, et al. 2022. Immunology. 165:274. PubMed
  104. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  105. Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed
  106. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
  107. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  108. Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed
  109. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  110. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  111. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  112. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  113. Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed
  114. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  115. Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed
  116. Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed
  117. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  118. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  119. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  120. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  121. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  122. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  123. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  124. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  125. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  126. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  127. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  128. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  129. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  130. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  131. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  132. Lu SX, et al. 2021. Cell. . PubMed
  133. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  134. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  135. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  136. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  137. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  138. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  139. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  140. Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed
  141. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  142. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  143. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  144. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  145. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  146. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  147. Köchl R, et al. 2020. Elife. 9:00. PubMed
  148. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  149. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  150. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  151. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  152. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  153. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  154. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  155. Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed
  156. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  157. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  158. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  159. Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed
  160. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  161. Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed
  162. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  163. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  164. Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed
  165. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  166. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  167. Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed
  168. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  169. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  170. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  171. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  172. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  173. Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed
  174. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  175. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  176. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  177. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  178. Koide S, et al. 2022. iScience. 25:103603. PubMed
  179. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  180. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  181. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  182. Anderson DA, et al. 2022. J Exp Med. 219:. PubMed
  183. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  184. Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed
  185. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  186. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  187. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  188. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  189. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  190. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  191. Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed
  192. Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed
  193. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  194. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  195. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  196. Deets KA, et al. 2021. Elife. 10:. PubMed
  197. Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed
  198. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  199. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  200. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  201. Muro R, et al. 2015. PLoS One. 10:119898. PubMed
  202. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_312669 (BioLegend Cat. No. 100304)
AB_312668 (BioLegend Cat. No. 100303)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account